| Control group | Treatment group | Adjusted β (95%CI) | P | Effect size (95%CI) | ||||
---|---|---|---|---|---|---|---|---|---|
N | Mean (SD) | Adjusted mean change (95%CI) from BL | N | Mean (SD) | Adjusted mean change (95%CI) from BL | ||||
Depression Cohort | |||||||||
 PHQ-9 | |||||||||
  Baseline | 72 | 12.3 (2.15) | – | 137 | 12.1 (4.13) | – | – | – |  |
  Midline | 49 | 6.3 (5.06) | −6.22 (−7.64 to −4.79) | 110 | 4.7 (4.32) | −7.09 (−8.17 to − 6.02) | −0.88 (−2.66 to 0.91) | 0.336 | − 0.17 (− 0.50, 0.17) |
  Endline | 55 | 6.6 (4.94) | −5.53 (− 6.91 to − 4.14) | 111 | 4.8 (4.60) | −6.93 (− 8.07 to − 5.78) | −1.40 (−3.20 to 0.40) | 0.127 | −0.25 (− 0.57, 0.07) |
 WHODAS | |||||||||
  Baseline | 72 | 30.0 (15.55) | – | 137 | 35.7 (18.55) | – | – | – |  |
  Midline | 49 | 21.7 (18.50) | −8.08 (− 13.62 to − 2.54) | 110 | 18.9 (18.83) | −14.70 (− 19.37 to − 10.03) | −6.62 (− 13.86 to 0.63) | 0.073 | −0.31 (− 0.64, 0.03) |
  Endline | 55 | 22.8 (18.89) | −6.71 (− 12.28 to − 1.13) | 111 | 19.8 (20.92) | − 13.90 (− 19.00 to − 8.81) | − 7.20 (− 14.75 to 0.35) | 0.062 | − 0.31 (− 0.63, 0.02) |
AUD Cohort | |||||||||
 AUDIT | |||||||||
  Baseline | 57 | 16.4 (6.53) | – | 175 | 25.4 (6.55) | – | – | – |  |
  Midline | 28 | 16.0 (5.92) | 1.66 (−0.83 to 4.15) | 135 | 10.4 (9.87) | −13.48 (− 15.94 to − 11.01) | −15.13 (− 18.63 to − 11.63) | < 0.001 | −1.76 (− 2.17, − 1.35) |
  Endline | 35 | 16.9 (9.04) | 1.09 (− 2.36 to 4.54) | 142 | 15.7 (10.74) | − 8.03 (− 10.59 to − 5.48) | −9.12 (− 13.41 to − 4.83) | < 0.001 | − 0.79 (− 1.16, − 0.42) |
 WHODAS | |||||||||
  Baseline | 57 | 17.5 (15.11) | – | 175 | 22.1 (17.90) | – | – | – |  |
  Midline | 28 | 13.4 (12.58) | − 2.57 (− 8.00 to 2.86) | 135 | 12.3 (15.77) | − 8.83 (− 12.75 to − 4.92) | − 6.26 (− 12.95 to 0.43) | 0.067 | −0.38 (− 0.79, 0.03) |
  Endline | 35 | 15.5 (13.03) | 1.23 (− 4.82 to 7.28) | 142 | 13.6 (14.33) | −8.03 (− 11.83 to − 4.23) | − 9.26 (− 16.41 to − 2.12) | 0.011 | − 0.48 (− 0.85, − 0.11) |